New European exhibition launch for pharma industry
Experts discuss England’s proposed ‘fast-track’ appraisals for new treatments, plus MAAs.
Experts call for urgent development of new drug funding mechanisms.
Three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
Exhibition & Conference for Pharma Professionals
Inefficient processes, legacy infrastructure and a silo culture are slowing access to critical trial data.
Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.